Stocks to watch, April 13, 2023: After TCS, all eyes will be on Infosys today as the Salil Parekh-led company is slated to release its Q4 earnings later in the day.
Stocks to watch today: Domestic equities are expected to open in the red on April 13 amid negative global cues. US stocks ended lower in the overnight trade after minutes from the Federal Reserve’s March policy meeting revealed concern among several members of the Federal Open Markets Committee (FOMC) regarding the regional bank liquidity crisis. However, cooler-than-expected inflation in March gave some solace. US CPI inflation came in at 5 per cent, which as per reports, was nearly a two-year low.
In Asia, MSCI’s broadest index of Asia-Pacific shares outside Japan slid 0.3 per cent, largely pressured by a 1.5 per cent drop in Hong Kong tech stocks in the wake of the Financial Times reporting SoftBank was selling down its Alibaba stake, Reuters reported. That apart, Nifty futures on the Singapore Exchange (SGX), too, pointed at a gloomy start for the Indian indices as at 08:10 am, the SGX Nifty traded 0.09 per cent lower at 17,863.5 levels.
Here’s a look at some of the stocks that may hog the limelight today:
Read More:-Govt Specifies Retail Sale Price Based GST Cess Rate For Pan Masala, Tobacco
TCS: The IT giant will be on investors’ radar as the company’s fourth-quarter results missed analysts’ expectations on most parameters and management commentary also sounded cautious. The Tata group IT major on April 12 reported a five per cent sequential increase in net profit to Rs 11,392 crore for the quarter ended March 2023. Its revenue grew 1.6 per cent to Rs 59,162 crore.
Infosys: After TCS, all eyes will be on Infosys today as the Salil Parekh-led company is slated to release its Q4 earnings later in the day.
RITES has received a work order for the PMC work from the Kerala Infrastructure Investment Fund Board (KIIFB) for their projects at an estimated fee of Rs 72 crore
Lupin: The pharma major’s arm Lupin Diagnostics has opened a regional reference laboratory in Bengaluru as part of the country-wide expansion of its diagnostics networks. Lupin currently has 25 such labs in the country.
AU Small Finance Bank: The Reserve Bank of India (RBI) on April 12 approved the reappointment of Sanjay Agarwal as Managing Director and CEO of AU Small Finance Bank.
Read More:-Personal Loan vs Loan Against Securities: Which is a better option for you?
SRF India: The company informed about the Board’s approval for a project to create a Pharma Intermediates Plant for undertaking precursor processes for the production of Pharma products at Dahej. “It is hereby informed that the project has been commissioned and capitalised on 12th April 2023 at an aggregate cost of Rs 223 crore (approx.),” the company said.
More to come…
